Foggy visual field defect

Survey of Ophthalmology

Volumn 49, Issue 2, 2004, Pages 266-267

  Vaphiades, Michael S ^a   Mason, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHENOTHIAZINE; TOPIRAMATE; VIGABATRIN;

ANAMNESIS; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; RETINA DISEASE; RETINA MACULOPATHY; SEIZURE; VISUAL ACUITY; VISUAL FIELD DEFECT;

ADULT; ANTICONVULSANTS; FEMALE; FRUCTOSE; HUMANS; RETINAL DISEASES; VISION DISORDERS; VISUAL FIELDS;

EID: 1542271651     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2003.12.004     Document Type: Letter

References (13)

1. Biton V., Montouris G.D., Ritter F., et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology. 52:1999;1330-1337.
2. Chong M.S., Libretto S.E. The rationale and use of topiramate for treating neuropathic pain. Clin J Pain. 19:2003;59-68.
3. McElroy S.L., Arnold L.M., Shapira N.A., et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry. 160:2003;225-261.
4. Rhee D.J., Goldberg M.J., Parrish R.K. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol. 119:2001;1721-1723.
5. Sachdeo R.C., Glauser T.A., Ritter F., et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology. 52:1999;1882-1887.
6. Sankar P.S., Pasquale L.R., Grosskreutz. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 119:2001;1210-1211.
7. Sen H.A., O'Halloran H.S., Lee W.B. Topiramate-induced acute myopia and retinal striae. Arch Ophthalmol. 119:2001;775-777.
8. Sharief M., Viteri C., Ben-Menachem E., et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res. 25:1996;217-224.
9. Smathers S.A., Wilson J.G., Nigro M.A. Topiramate effectiveness in Prader-Willi syndrome. Pediatric Neurology. 28:2003;130-133.
10. Suppes T. Review of the use of topiramate for treatment of bipolar disorders. J Clin Psychopharmacol. 22:2002;599-609.
11. Thompson P.J., Baxendale S.A., Duncan J.S., Sander J.W.A.S. Effects of topiramate on cognitive function. J Neurol Neurosurg Psych. 69:2000;636-641.
12. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., Wolf H.H. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia. 41:(suppl 1):1997;S17-S20.
13. Young W.B., Hopkins M.M., Shechter A.L., Silberstein S.D. Topiramate: a case series study in migraine prophylaxis. Cephalalgia. 22:2002;659-663.